Gemez 320mg Tablet
By Gemez
Rx
5 Tablet in a Strip

Composition
Gemifloxacin(320mg)

Manufacturer - Glenmark Pharmaceuticals Ltd
Glenmark Pharmaceuticals Limited, B/2, Mahalaxmi Chambers, 22, Bhulabhai Desai Road, Mumbai – 400 026.

Expires on or after
October, 2025

liver
Gemez 320mg Tablet is considered safe for use in patients with liver disease. It is important to note that no dose adjustment of Gemez 320mg Tablet is recommended specifically for individuals with liver issues. It is advisable to adhere to the prescribed dosage and follow the guidance of your healthcare provider when using this medication, even if you have a liver condition. If you have any concerns or questions regarding the use of Gemez 320mg Tablet in relation to your liver health, please consult with your healthcare provider for personalized advice.

kidney
Gemez 320mg Tablet may require caution in individuals with kidney problems. Adjusting the dosage might be necessary. Always seek advice from your doctor regarding kidney health and the use of this medication.

alcohol
It is safe to consume alcohol while taking Gemez 320mg Tablet as it does not lead to any harmful side effects.

driving
When taking Gemez 320mg Tablet, be cautious as it may cause decreased alertness, affect vision, or induce sleepiness and dizziness. It is advised not to drive when experiencing these symptoms.

pregnancy
Gemez 320mg Tablet is considered unsafe during pregnancy due to potential risks to the baby. Consult your doctor before use. It may be prescribed in life-threatening situations if benefits outweigh risks.

breastfeeding
During breastfeeding, it is advised to use Gemez 320mg Tablet with caution. It is recommended to pause breastfeeding until the mother's treatment is finished and the drug is no longer present in her body.
Habit Forming | No |
Chemical Class | Fluoroquinolone |
Therapeutic Class | GASTRO INTESTINAL |
Action Class | Quinolones/ Fluroquinolones |
₹86.18
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 11-Feb-2025